Biomarkers for CNS involvement in pediatric lupus

Area of Science:

• Pediatric Rheumatology
• Neuroimmunology
• Biomarker Discovery

Background:

• Central neuropsychiatric lupus erythematosus (cNPSLE) frequently affects pediatric lupus patients, causing significant morbidity and poor long-term outcomes.
• Diagnosing cNPSLE in children is difficult due to invasive/costly tools and lack of screening mechanisms.
• Differentiating primary cNPSLE from other causes is a major diagnostic challenge.

Purpose of the Study:

• To address the diagnostic challenges of cNPSLE in pediatric lupus.
• To explore the need for novel biomarkers for accurate cNPSLE diagnosis.
• To guide the development of accessible and reliable biomarkers for pediatric populations.

Main Methods:

• Review of current diagnostic challenges in pediatric cNPSLE.
• Discussion of the role of multi-modal biomarker profiles (molecular, psychometric, neuroimaging).
• Emphasis on the need for noninvasive and reliable pediatric-specific diagnostic approaches.

Main Results:

• Current diagnostic tools for cNPSLE in children are often invasive or expensive.
• There is a lack of accepted screening mechanisms for pediatric cNPSLE.
• Biomarker research is crucial for differentiating primary cNPSLE from other conditions.

Conclusions:

• Developing noninvasive and reliable biomarkers is essential for improving the care of children with lupus.
• Multi-modal biomarker approaches are likely necessary for comprehensive cNPSLE diagnosis.
• Accessible screening tools are needed to improve early detection and management of pediatric cNPSLE.